MA42811B1 - Dérivés d'indole monosubstitués ou disubstitués utilisés en tant qu'inhibiteurs de la réplication du virus de la dengue - Google Patents
Dérivés d'indole monosubstitués ou disubstitués utilisés en tant qu'inhibiteurs de la réplication du virus de la dengueInfo
- Publication number
- MA42811B1 MA42811B1 MA42811A MA42811A MA42811B1 MA 42811 B1 MA42811 B1 MA 42811B1 MA 42811 A MA42811 A MA 42811A MA 42811 A MA42811 A MA 42811A MA 42811 B1 MA42811 B1 MA 42811B1
- Authority
- MA
- Morocco
- Prior art keywords
- monosubstituted
- inhibitors
- compounds
- dengue virus
- virus replication
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/12—Radicals substituted by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
La présente invention concerne des composés indoles mono- ou di-substitués, des procédés pour prévenir ou traiter les infections virales de la dengue en utilisant lesdits composés et concerne également lesdits composés à utiliser comme médicament, plus préférablement à utiliser comme médicament pour traiter ou prévenir la dengue virale infections. La présente invention concerne en outre des compositions pharmaceutiques ou des préparations combinées des composés, des compositions ou des préparations destinées à être utilisées comme médicament, plus préférablement pour la prévention ou le traitement des infections virales de la dengue. L'invention concerne également des procédés de préparation des composés.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP15185522 | 2015-09-16 | ||
EP16163465 | 2016-04-01 | ||
PCT/EP2016/071852 WO2017046258A1 (fr) | 2015-09-16 | 2016-09-15 | Dérivés d'indole monosubstitués ou disubstitués utilisés en tant qu'inhibiteurs de la réplication du virus de la dengue |
Publications (2)
Publication Number | Publication Date |
---|---|
MA42811A MA42811A (fr) | 2018-07-25 |
MA42811B1 true MA42811B1 (fr) | 2020-03-31 |
Family
ID=56958913
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA42811A MA42811B1 (fr) | 2015-09-16 | 2016-09-15 | Dérivés d'indole monosubstitués ou disubstitués utilisés en tant qu'inhibiteurs de la réplication du virus de la dengue |
Country Status (37)
Country | Link |
---|---|
US (1) | US10786484B2 (fr) |
EP (1) | EP3350163B1 (fr) |
JP (2) | JP7045984B2 (fr) |
KR (1) | KR20180051563A (fr) |
CN (1) | CN108368044B (fr) |
AU (1) | AU2016323535B2 (fr) |
CA (1) | CA2996856C (fr) |
CL (1) | CL2018000697A1 (fr) |
CO (1) | CO2018003369A2 (fr) |
CR (1) | CR20180214A (fr) |
CY (1) | CY1122792T1 (fr) |
DK (1) | DK3350163T3 (fr) |
EA (1) | EA035679B1 (fr) |
EC (1) | ECSP18020039A (fr) |
ES (1) | ES2778431T3 (fr) |
HK (1) | HK1258320A1 (fr) |
HR (1) | HRP20200408T1 (fr) |
IL (1) | IL258031B (fr) |
JO (1) | JO3633B1 (fr) |
LT (1) | LT3350163T (fr) |
MA (1) | MA42811B1 (fr) |
MD (1) | MD3350163T2 (fr) |
ME (1) | ME03674B (fr) |
MX (1) | MX2018003256A (fr) |
MY (1) | MY188347A (fr) |
NI (1) | NI201800040A (fr) |
PE (1) | PE20181007A1 (fr) |
PH (1) | PH12018500569A1 (fr) |
PL (1) | PL3350163T3 (fr) |
PT (1) | PT3350163T (fr) |
RS (1) | RS60039B1 (fr) |
SI (1) | SI3350163T1 (fr) |
TW (1) | TWI758256B (fr) |
UA (1) | UA123672C2 (fr) |
UY (1) | UY36904A (fr) |
WO (1) | WO2017046258A1 (fr) |
ZA (1) | ZA201801764B (fr) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201116559D0 (en) | 2011-09-26 | 2011-11-09 | Univ Leuven Kath | Novel viral replication inhibitors |
KR101818521B1 (ko) * | 2011-11-16 | 2018-01-16 | 대우조선해양 주식회사 | 마이크로채널 열교환기용 2상 유체 공급장치 및 그 방법 |
GB201305376D0 (en) | 2013-03-25 | 2013-05-08 | Univ Leuven Kath | Novel viral replication inhibitors |
JOP20160086B1 (ar) | 2015-05-08 | 2021-08-17 | 2 Katholieke Univ Leuven Ku Leuven Research And Development | مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
JOP20160198B1 (ar) | 2015-09-16 | 2022-03-14 | Janssen Pharmaceuticals Inc | مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
AU2016373530B2 (en) | 2015-12-16 | 2021-01-21 | Loxo Oncology, Inc. | Compounds useful as kinase inhibitors |
BR112018069601A2 (pt) | 2016-03-31 | 2019-01-29 | Janssen Pharmaceuticals Inc | derivados de indolina substituídos como inibidores da replicação viral da dengue |
CR20180495A (es) | 2016-03-31 | 2018-12-06 | Univ Leuven Kath | Deribados de indol sustituidos como inhibidores de replicación viral del dengue |
MA44502A (fr) | 2016-04-01 | 2019-02-06 | Janssen Pharmaceuticals Inc | Dérivés d'indole substitués utilisés en tant qu'inhibiteurs de réplication du virus de la dengue |
JOP20170069B1 (ar) | 2016-04-01 | 2021-08-17 | 1 Janssen Pharmaceuticals Inc | مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
JOP20180026A1 (ar) | 2017-03-31 | 2019-01-30 | Univ Leuven Kath | مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
JOP20180025B1 (ar) | 2017-03-31 | 2021-08-17 | Janssen Pharmaceuticals Inc | مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
KR102625988B1 (ko) | 2017-05-22 | 2024-01-16 | 얀센 파마슈티칼즈, 인코포레이티드 | 뎅기 바이러스 복제 억제제로서의 치환 인돌린 유도체 |
IL270727B2 (en) | 2017-05-22 | 2023-03-01 | Janssen Pharmaceuticals Inc | Transduced indulin derivatives as inhibitors of dengue virus replication |
Family Cites Families (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0110832D0 (en) | 2001-05-03 | 2001-06-27 | Virogen Ltd | Antiviral compounds |
CA2468202A1 (fr) | 2001-12-12 | 2003-06-19 | Conforma Therapeutics Corporation | Essais et mises en oeuvre permettant de determiner et de moduler une activite de liaison hsp90 |
GB0215293D0 (en) | 2002-07-03 | 2002-08-14 | Rega Foundation | Viral inhibitors |
AU2006204917A1 (en) | 2005-01-14 | 2006-07-20 | Smithkline Beecham Corporation | Indole derivatives for treating viral infections |
EP1853317A2 (fr) | 2005-02-09 | 2007-11-14 | Migenix Inc. | Compositions et methodes permettant de traiter ou de prevenir les infections par les flaviviridae |
FR2928645A1 (fr) * | 2008-03-14 | 2009-09-18 | Sanofi Aventis Sa | Nouveaux derives de carbazole inhibiteurs d'hsp90, compositions les contenant et utilisation |
US9029376B2 (en) | 2008-06-03 | 2015-05-12 | Siga Technologies, Inc. | Small molecule inhibitors for the treatment or prevention of dengue virus infection |
EP2326631A4 (fr) * | 2008-08-18 | 2012-03-21 | Univ Yale | Modulateurs de mif |
WO2010021878A1 (fr) | 2008-08-19 | 2010-02-25 | Janssen Pharmaceutica Nv | Antagonistes des récepteurs au froid activés par le menthol |
TWI453207B (zh) | 2008-09-08 | 2014-09-21 | Signal Pharm Llc | 胺基***并吡啶,其組合物及使用其之治療方法 |
GB0910003D0 (en) * | 2009-06-11 | 2009-07-22 | Univ Leuven Kath | Novel compounds for the treatment of neurodegenerative diseases |
US8993604B2 (en) | 2009-06-30 | 2015-03-31 | Siga Technologies, Inc. | Treatment and prevention of dengue virus infections |
US8524764B2 (en) | 2010-01-15 | 2013-09-03 | Gilead Sciences, Inc. | Inhibitors of Flaviviridae viruses |
JP5716205B2 (ja) * | 2011-03-29 | 2015-05-13 | 学校法人日本大学 | グルコシダーゼ活性阻害用組成物及びそのスクリーニング方法 |
GB201116559D0 (en) * | 2011-09-26 | 2011-11-09 | Univ Leuven Kath | Novel viral replication inhibitors |
GB201305376D0 (en) * | 2013-03-25 | 2013-05-08 | Univ Leuven Kath | Novel viral replication inhibitors |
KR102290189B1 (ko) * | 2013-10-23 | 2021-08-17 | 얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 | 카르복스아미드 유도체 및 b형 간염 치료용 의약으로서의 이의 용도 |
MX2016009230A (es) | 2014-01-31 | 2016-10-03 | Bristol Myers Squibb Co | Macrociclicos con grupos p2'heterociclicos como inhibidores del factor xia. |
KR102478309B1 (ko) | 2014-10-01 | 2022-12-15 | 얀센 파마슈티칼즈, 인코포레이티드 | 뎅기 바이러스 복제 억제제로서의 1치환 또는 2치환 인돌 |
NO2721243T3 (fr) | 2014-10-01 | 2018-10-20 | ||
PT3201176T (pt) | 2014-10-01 | 2019-03-04 | Janssen Pharmaceuticals Inc | Derivados indol mono- ou dissubstituídos como inibidores da replicação viral do dengue |
JOP20150335B1 (ar) * | 2015-01-16 | 2022-03-14 | Janssen Pharmaceuticals Inc | مشتقات اندول بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
AR103680A1 (es) | 2015-02-23 | 2017-05-24 | Lilly Co Eli | Inhibidores selectivos de bace1 |
JOP20160086B1 (ar) | 2015-05-08 | 2021-08-17 | 2 Katholieke Univ Leuven Ku Leuven Research And Development | مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
JOP20160198B1 (ar) * | 2015-09-16 | 2022-03-14 | Janssen Pharmaceuticals Inc | مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
AU2016350868B2 (en) | 2015-11-03 | 2022-03-31 | Zoetis Services Llc | Sol-gel polymer composites and uses thereof |
AU2017245125B2 (en) | 2016-03-31 | 2020-10-22 | Takeda Pharmaceutical Company Limited | Heterocyclic compound |
BR112018069601A2 (pt) | 2016-03-31 | 2019-01-29 | Janssen Pharmaceuticals Inc | derivados de indolina substituídos como inibidores da replicação viral da dengue |
CR20180495A (es) | 2016-03-31 | 2018-12-06 | Univ Leuven Kath | Deribados de indol sustituidos como inhibidores de replicación viral del dengue |
JOP20170069B1 (ar) | 2016-04-01 | 2021-08-17 | 1 Janssen Pharmaceuticals Inc | مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
EA039392B1 (ru) | 2016-04-01 | 2022-01-21 | СИГНАЛ ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи | Способ лечения рака с применением замещенного аминопуринового соединения |
KR102120815B1 (ko) | 2016-04-01 | 2020-06-12 | 카이트 파마 인코포레이티드 | 키메라 수용체 및 그의 사용 방법 |
CN108779121A (zh) | 2016-04-01 | 2018-11-09 | 巴斯夫欧洲公司 | 双环化合物 |
WO2017173410A1 (fr) | 2016-04-01 | 2017-10-05 | Amgen Inc. | Récepteurs chimères de flt3 et leurs procédés d'utilisation |
PL3436079T3 (pl) | 2016-04-01 | 2021-12-20 | Kite Pharma, Inc. | Antygen chimeryczny i receptory komórek t oraz sposoby ich stosowania |
MA44502A (fr) | 2016-04-01 | 2019-02-06 | Janssen Pharmaceuticals Inc | Dérivés d'indole substitués utilisés en tant qu'inhibiteurs de réplication du virus de la dengue |
JOP20180026A1 (ar) | 2017-03-31 | 2019-01-30 | Univ Leuven Kath | مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
JOP20180025B1 (ar) | 2017-03-31 | 2021-08-17 | Janssen Pharmaceuticals Inc | مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
KR102625988B1 (ko) | 2017-05-22 | 2024-01-16 | 얀센 파마슈티칼즈, 인코포레이티드 | 뎅기 바이러스 복제 억제제로서의 치환 인돌린 유도체 |
IL270727B2 (en) | 2017-05-22 | 2023-03-01 | Janssen Pharmaceuticals Inc | Transduced indulin derivatives as inhibitors of dengue virus replication |
-
2016
- 2016-09-06 JO JOP/2016/0197A patent/JO3633B1/ar active
- 2016-09-13 TW TW105129691A patent/TWI758256B/zh active
- 2016-09-15 PT PT167672351T patent/PT3350163T/pt unknown
- 2016-09-15 MX MX2018003256A patent/MX2018003256A/es unknown
- 2016-09-15 US US15/759,844 patent/US10786484B2/en active Active
- 2016-09-15 DK DK16767235.1T patent/DK3350163T3/da active
- 2016-09-15 AU AU2016323535A patent/AU2016323535B2/en active Active
- 2016-09-15 EA EA201890723A patent/EA035679B1/ru not_active IP Right Cessation
- 2016-09-15 CR CR20180214A patent/CR20180214A/es unknown
- 2016-09-15 ES ES16767235T patent/ES2778431T3/es active Active
- 2016-09-15 MA MA42811A patent/MA42811B1/fr unknown
- 2016-09-15 CA CA2996856A patent/CA2996856C/fr active Active
- 2016-09-15 LT LTEP16767235.1T patent/LT3350163T/lt unknown
- 2016-09-15 EP EP16767235.1A patent/EP3350163B1/fr active Active
- 2016-09-15 SI SI201630686T patent/SI3350163T1/sl unknown
- 2016-09-15 MD MDE20180704T patent/MD3350163T2/ro unknown
- 2016-09-15 PE PE2018000391A patent/PE20181007A1/es unknown
- 2016-09-15 KR KR1020187009485A patent/KR20180051563A/ko active IP Right Grant
- 2016-09-15 ME MEP-2020-53A patent/ME03674B/fr unknown
- 2016-09-15 CN CN201680053589.9A patent/CN108368044B/zh active Active
- 2016-09-15 JP JP2018513845A patent/JP7045984B2/ja active Active
- 2016-09-15 MY MYPI2018000378A patent/MY188347A/en unknown
- 2016-09-15 PL PL16767235T patent/PL3350163T3/pl unknown
- 2016-09-15 UA UAA201804016A patent/UA123672C2/uk unknown
- 2016-09-15 RS RS20200272A patent/RS60039B1/sr unknown
- 2016-09-15 WO PCT/EP2016/071852 patent/WO2017046258A1/fr active Application Filing
- 2016-09-16 UY UY0001036904A patent/UY36904A/es not_active Application Discontinuation
-
2018
- 2018-03-12 IL IL258031A patent/IL258031B/en active IP Right Grant
- 2018-03-14 EC ECIEPI201820039A patent/ECSP18020039A/es unknown
- 2018-03-15 NI NI201800040A patent/NI201800040A/es unknown
- 2018-03-15 ZA ZA2018/01764A patent/ZA201801764B/en unknown
- 2018-03-15 CL CL2018000697A patent/CL2018000697A1/es unknown
- 2018-03-15 PH PH12018500569A patent/PH12018500569A1/en unknown
- 2018-03-26 CO CONC2018/0003369A patent/CO2018003369A2/es unknown
-
2019
- 2019-01-16 HK HK19100688.6A patent/HK1258320A1/zh not_active IP Right Cessation
-
2020
- 2020-03-12 HR HRP20200408TT patent/HRP20200408T1/hr unknown
- 2020-03-12 CY CY20201100216T patent/CY1122792T1/el unknown
-
2021
- 2021-08-20 JP JP2021135171A patent/JP2021193092A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA42811B1 (fr) | Dérivés d'indole monosubstitués ou disubstitués utilisés en tant qu'inhibiteurs de la réplication du virus de la dengue | |
MA40769B1 (fr) | Indoles mono ou di-substitués utilisés en tant qu'inhibiteurs de réplication du virus de la dengue | |
MA40768B1 (fr) | Dérivés d'indole mono ou di-substitué en tant qu'inhibiteurs de réplication du virus de la dengue | |
PH12018502026A1 (en) | Substituted indole compound derivatives as dengue viral replication inhibitors | |
PH12019502201A1 (en) | Substituted indoline derivatives as dengue viral replication inhibitors | |
PH12019502577A1 (en) | Substituted indoline derivatives as dengue viral replication inhibitors | |
PH12018502016A1 (en) | Substituted indole derivatives as dengue viral replication inhibitors | |
JOP20210109A1 (ar) | مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك | |
PH12018502077A1 (en) | Substituted indoline derivatives as dengue viral replication inhibitors | |
PH12019502095A1 (en) | Substituted indoline derivatives as dengue viral replication inhibitors | |
PH12018502015A1 (en) | Substituted indole derivatives as dengue viral replication inhibitors | |
PH12019502559A1 (en) | Substituted indoline derivatives as dengue viral replication inhibitors | |
PH12018500576A1 (en) | Mono- or di-substituted indole derivatives as dengue viral replication inhibitors | |
CL2017001822A1 (es) | Derivados de indol mono o disustituido como inhibidores de la replicación del virus del dengue | |
MA43507B1 (fr) | Dérivés d'indole mono ou di-substitué en tant qu'inhibiteurs de réplication du virus de la dengue | |
EA201992295A1 (ru) | Производные моно- или дизамещенных индолов в качестве ингибиторов репликации вирусов денге |